Colchicine use in children and adolescents with familial Mediterranean fever: Literature review and consensus statement

被引:185
作者
Kallinich, Tilmann
Haffner, Dieter
Niehues, Tim
Huss, Kristina
Lainka, Elke
Neudorf, Ulrich
Schaefer, Christof
Stojanov, Silvia
Timmann, Christian
Keitzer, Rolf
Ozdogan, Huri
Ozen, Seza
机构
[1] Univ Med Berlin, Dept Pediat Pneumol & Immunol, Berlin, Germany
[2] Univ Hosp Rostock, Dept Pediat, Rostock, Germany
[3] Univ Dusseldorf, Dept Pediat Oncol Hematol & Immunol, D-4000 Dusseldorf, Germany
[4] Univ Duisburg Gesamthsch, Dept Pediat, D-4100 Duisburg, Germany
[5] Childrens Univ Hosp, Dept Infect Dis & Immunol, Munich, Germany
[6] Berliner Betrieb Zent Gesundheitl Aufugaben, Berlin, Germany
[7] Bernhard Nocht Inst Trop Med, Dept Mol Med, Hamburg, Germany
[8] Istanbul Univ, Cerrahpasa Med Sch, Cerrahpasa, Turkey
[9] Hacettepe Univ, Fac Med, Dept Pediat Nephrol & Rheumatol, Ankara, Turkey
关键词
familial Mediterranean fever; colchicine; evidence-based guidelines; treatment;
D O I
10.1542/peds.2006-1434
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The daily application of colchicine is the standard therapy for prophylaxis of attacks and amyloid deposition in familial Mediterranean fever. However, because of many issues (eg, dosage, time of introduction, etc), no standardized treatment recommendations have been established. In this work we review the available literature on colchicine use with respect to its indication, efficacy, mode of application, and safety in children and adolescents with familial Mediterranean fever. On the basis of this analysis, a consensus statement on the application of colchicine in children and adolescents with familial Mediterranean fever was developed by caregivers from Germany, Austria, and Turkey.
引用
收藏
页码:E474 / E483
页数:10
相关论文
共 145 条
[71]   LONG-TERM COLCHICINE THERAPY OF FAMILIAL MEDITERRANEAN FEVER [J].
LEHMAN, TJA ;
PETERS, RS ;
HANSON, V ;
SCHWABE, AD .
JOURNAL OF PEDIATRICS, 1978, 93 (05) :876-878
[72]   THE EFFECT OF LIVER DYSFUNCTION ON COLCHICINE PHARMACOKINETICS IN THE RAT [J].
LEIGHTON, JA ;
BAY, MK ;
MALDONADO, AL ;
JOHNSON, RF ;
SCHENKER, S ;
SPEEG, KV .
HEPATOLOGY, 1990, 11 (02) :210-215
[73]  
LEIGHTON JA, 1991, HEPATOLOGY, V14, P1013, DOI 10.1002/hep.1840140611
[74]  
LEVY M, 1978, FERTIL STERIL, V29, P667
[75]   LONG-TERM COLCHICINE PROPHYLAXIS IN FAMILIAL MEDITERRANEAN FEVER [J].
LEVY, M ;
ELIAKIM, M .
BMJ-BRITISH MEDICAL JOURNAL, 1977, 2 (6090) :808-808
[76]  
Lidar M, 2003, J RHEUMATOL, V30, P2620
[77]   COLCHICINE TREATMENT OF AA AMYLOIDOSIS OF FAMILIAL MEDITERRANEAN FEVER - AN ANALYSIS OF FACTORS AFFECTING OUTCOME [J].
LIVNEH, A ;
ZEMER, D ;
LANGEVITZ, P ;
LAOR, A ;
SOHAR, E ;
PRAS, M .
ARTHRITIS AND RHEUMATISM, 1994, 37 (12) :1804-1811
[78]   MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever [J].
Livneh, A ;
Langevitz, P ;
Shinar, Y ;
Zaks, N ;
Kastner, DL ;
Pras, M ;
Pras, E .
AMYLOID-INTERNATIONAL JOURNAL OF EXPERIMENTAL AND CLINICAL INVESTIGATION, 1999, 6 (01) :1-6
[79]   COLCHICINE PREVENTS KIDNEY-TRANSPLANT AMYLOIDOSIS IN FAMILIAL MEDITERRANEAN FEVER [J].
LIVNEH, A ;
ZEMER, D ;
SIEGAL, B ;
LAOR, A ;
SOHAR, E ;
PRAS, M .
NEPHRON, 1992, 60 (04) :418-422
[80]   HYPERSENSITIVITY TO COLCHICINE [J].
MACLEOD, JG ;
PHILLIPS, L .
ANNALS OF THE RHEUMATIC DISEASES, 1947, 6 (04) :224-229